カテゴリー： QYResearch, 世界

多嚢胞性卵巣症候群治療の世界市場：規模・現状・予測

◆英語タイトル：Global Polycystic Ovary Syndrome Treatment Market Size, Status and Forecast 2019-2025
◆商品コード：DATA909X18844
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月25日（※2024年版があります。お問い合わせください）
◆ページ数：91
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,900 ⇒換算￥577,200	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,850 ⇒換算￥865,800	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,800 ⇒換算￥1,154,400	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※当調査レポートでは、多嚢胞性卵巣症候群治療の世界市場について調査・分析し、多嚢胞性卵巣症候群治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（経口避妊薬、インスリン抵抗性改善薬、抗うつ薬、オルニチンデカルボキシラーゼ阻害薬、アロマターゼ阻害薬、利尿薬）、用途別（病院薬局、ドラッグストア）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。

・レポートの概要
・世界の多嚢胞性卵巣症候群治療市場動向
・主要企業別マーケットシェア
・多嚢胞性卵巣症候群治療の種類別市場規模2014-2019
（経口避妊薬、インスリン抵抗性改善薬、抗うつ薬、オルニチンデカルボキシラーゼ阻害薬、アロマターゼ阻害薬、利尿薬）
・多嚢胞性卵巣症候群治療の用途別市場規模2014-2019
（病院薬局、ドラッグストア）
・多嚢胞性卵巣症候群治療の北米市場：主要企業・種類別/用途別市場規模
・多嚢胞性卵巣症候群治療のヨーロッパ市場：主要企業・種類別/用途別市場規模
・多嚢胞性卵巣症候群治療の中国市場：主要企業・種類別/用途別市場規模
・多嚢胞性卵巣症候群治療の日本国内市場：主要企業・種類別/用途別市場規模
・多嚢胞性卵巣症候群治療の東南アジア市場：主要企業・種類別/用途別市場規模
・多嚢胞性卵巣症候群治療のインド市場：主要企業・種類別/用途別市場規模
・多嚢胞性卵巣症候群治療の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Sanofi、Novartis AG、Teva Pharmaceutical Industries Limited 、Addex Therapeutics Ltd. 、BIOCAD、Merck KGaA、AstraZeneca plc.、Bristol Myers Squibb Co. 、Ferring Pharmaceuticals, Inc.、Crinetics Pharmaceuticals, Inc.）
・多嚢胞性卵巣症候群治療の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...

【レポートの概要】

Polycystic Ovary Syndrome Treatment means treatment of a common hormonal endocrine disorder that affects women of child bearing age (15 to 49 years). This disease is characterized by the formation of cysts on the ovaries leading to an insufficiency of the ovulation initiating hormone in the female body.In 2018, the global Polycystic Ovary Syndrome Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Polycystic Ovary Syndrome Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Polycystic Ovary Syndrome Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Sanofi
Novartis AG
Teva Pharmaceutical Industries Limited
Addex Therapeutics Ltd.
BIOCAD
Merck KGaA
AstraZeneca plc.
Bristol Myers Squibb Co.
Ferring Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc.

Market segment by Type, the product can be split into
Oral Contraceptives
Insulin Sensitizing Agents
Anti-Depressants
Ornithine Decarboxylase Inhibitors
Aromatase Inhibitors
Diuretics

Market segment by Application, split into
Hospital Pharmacies
Drug Stores

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Polycystic Ovary Syndrome Treatment status, future forecast, growth opportunity, key market and key players.
To present the Polycystic Ovary Syndrome Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Polycystic Ovary Syndrome Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Polycystic Ovary Syndrome Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Oral Contraceptives
1.4.3 Insulin Sensitizing Agents
1.4.4 Anti-Depressants
1.4.5 Ornithine Decarboxylase Inhibitors
1.4.6 Aromatase Inhibitors
1.4.7 Diuretics
1.5 Market by Application
1.5.1 Global Polycystic Ovary Syndrome Treatment Market Share by Application (2019-2025)
1.5.2 Hospital Pharmacies
1.5.3 Drug Stores
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Polycystic Ovary Syndrome Treatment Market Size
2.2 Polycystic Ovary Syndrome Treatment Growth Trends by Regions
2.2.1 Polycystic Ovary Syndrome Treatment Market Size by Regions (2019-2025)
2.2.2 Polycystic Ovary Syndrome Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Polycystic Ovary Syndrome Treatment Market Size by by Players
3.1.1 Global Polycystic Ovary Syndrome Treatment Revenue by by Players (2014-2019)
3.1.2 Global Polycystic Ovary Syndrome Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Polycystic Ovary Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Polycystic Ovary Syndrome Treatment Key Players Head office and Area Served
3.3 Key Players Polycystic Ovary Syndrome Treatment Product/Solution/Service
3.4 Date of Enter into Polycystic Ovary Syndrome Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Polycystic Ovary Syndrome Treatment Market Size by Type (2014-2019)
4.2 Global Polycystic Ovary Syndrome Treatment Market Size by Application (2014-2019)

5 North America
5.1 North America Polycystic Ovary Syndrome Treatment Market Size (2014-2019)
5.2 Polycystic Ovary Syndrome Treatment Key Players in North America
5.3 North America Polycystic Ovary Syndrome Treatment Market Size by Type
5.4 North America Polycystic Ovary Syndrome Treatment Market Size by Application

6 Europe
6.1 Europe Polycystic Ovary Syndrome Treatment Market Size (2014-2019)
6.2 Polycystic Ovary Syndrome Treatment Key Players in Europe
6.3 Europe Polycystic Ovary Syndrome Treatment Market Size by Type
6.4 Europe Polycystic Ovary Syndrome Treatment Market Size by Application

7 China
7.1 China Polycystic Ovary Syndrome Treatment Market Size (2014-2019)
7.2 Polycystic Ovary Syndrome Treatment Key Players in China
7.3 China Polycystic Ovary Syndrome Treatment Market Size by Type
7.4 China Polycystic Ovary Syndrome Treatment Market Size by Application

8 Japan
8.1 Japan Polycystic Ovary Syndrome Treatment Market Size (2014-2019)
8.2 Polycystic Ovary Syndrome Treatment Key Players in Japan
8.3 Japan Polycystic Ovary Syndrome Treatment Market Size by Type
8.4 Japan Polycystic Ovary Syndrome Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Polycystic Ovary Syndrome Treatment Market Size (2014-2019)
9.2 Polycystic Ovary Syndrome Treatment Key Players in Southeast Asia
9.3 Southeast Asia Polycystic Ovary Syndrome Treatment Market Size by Type
9.4 Southeast Asia Polycystic Ovary Syndrome Treatment Market Size by Application

10 India
10.1 India Polycystic Ovary Syndrome Treatment Market Size (2014-2019)
10.2 Polycystic Ovary Syndrome Treatment Key Players in India
10.3 India Polycystic Ovary Syndrome Treatment Market Size by Type
10.4 India Polycystic Ovary Syndrome Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Polycystic Ovary Syndrome Treatment Market Size (2014-2019)
11.2 Polycystic Ovary Syndrome Treatment Key Players in Central & South America
11.3 Central & South America Polycystic Ovary Syndrome Treatment Market Size by Type
11.4 Central & South America Polycystic Ovary Syndrome Treatment Market Size by Application

12 International Players Profiles
12.1 Sanofi
12.1.1 Sanofi Company Details
12.1.2 Company Description and Business Overview
12.1.3 Polycystic Ovary Syndrome Treatment Introduction
12.1.4 Sanofi Revenue in Polycystic Ovary Syndrome Treatment Business (2014-2019))
12.1.5 Sanofi Recent Development
12.2 Novartis AG
12.2.1 Novartis AG Company Details
12.2.2 Company Description and Business Overview
12.2.3 Polycystic Ovary Syndrome Treatment Introduction
12.2.4 Novartis AG Revenue in Polycystic Ovary Syndrome Treatment Business (2014-2019)
12.2.5 Novartis AG Recent Development
12.3 Teva Pharmaceutical Industries Limited
12.3.1 Teva Pharmaceutical Industries Limited Company Details
12.3.2 Company Description and Business Overview
12.3.3 Polycystic Ovary Syndrome Treatment Introduction
12.3.4 Teva Pharmaceutical Industries Limited Revenue in Polycystic Ovary Syndrome Treatment Business (2014-2019)
12.3.5 Teva Pharmaceutical Industries Limited Recent Development
12.4 Addex Therapeutics Ltd.
12.4.1 Addex Therapeutics Ltd. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Polycystic Ovary Syndrome Treatment Introduction
12.4.4 Addex Therapeutics Ltd. Revenue in Polycystic Ovary Syndrome Treatment Business (2014-2019)
12.4.5 Addex Therapeutics Ltd. Recent Development
12.5 BIOCAD
12.5.1 BIOCAD Company Details
12.5.2 Company Description and Business Overview
12.5.3 Polycystic Ovary Syndrome Treatment Introduction
12.5.4 BIOCAD Revenue in Polycystic Ovary Syndrome Treatment Business (2014-2019)
12.5.5 BIOCAD Recent Development
12.6 Merck KGaA
12.6.1 Merck KGaA Company Details
12.6.2 Company Description and Business Overview
12.6.3 Polycystic Ovary Syndrome Treatment Introduction
12.6.4 Merck KGaA Revenue in Polycystic Ovary Syndrome Treatment Business (2014-2019)
12.6.5 Merck KGaA Recent Development
12.7 AstraZeneca plc.
12.7.1 AstraZeneca plc. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Polycystic Ovary Syndrome Treatment Introduction
12.7.4 AstraZeneca plc. Revenue in Polycystic Ovary Syndrome Treatment Business (2014-2019)
12.7.5 AstraZeneca plc. Recent Development
12.8 Bristol Myers Squibb Co.
12.8.1 Bristol Myers Squibb Co. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Polycystic Ovary Syndrome Treatment Introduction
12.8.4 Bristol Myers Squibb Co. Revenue in Polycystic Ovary Syndrome Treatment Business (2014-2019)
12.8.5 Bristol Myers Squibb Co. Recent Development
12.9 Ferring Pharmaceuticals, Inc.
12.9.1 Ferring Pharmaceuticals, Inc. Company Details
12.9.2 Company Description and Business Overview
12.9.3 Polycystic Ovary Syndrome Treatment Introduction
12.9.4 Ferring Pharmaceuticals, Inc. Revenue in Polycystic Ovary Syndrome Treatment Business (2014-2019)
12.9.5 Ferring Pharmaceuticals, Inc. Recent Development
12.10 Crinetics Pharmaceuticals, Inc.
12.10.1 Crinetics Pharmaceuticals, Inc. Company Details
12.10.2 Company Description and Business Overview
12.10.3 Polycystic Ovary Syndrome Treatment Introduction
12.10.4 Crinetics Pharmaceuticals, Inc. Revenue in Polycystic Ovary Syndrome Treatment Business (2014-2019)
12.10.5 Crinetics Pharmaceuticals, Inc. Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Polycystic Ovary Syndrome Treatment Key Market Segments
Table Key Players Polycystic Ovary Syndrome Treatment Covered
Table Global Polycystic Ovary Syndrome Treatment Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Oral Contraceptives Figures
Table Key Players of Oral Contraceptives
Figuer Insulin Sensitizing Agents Figures
Table Key Players of Insulin Sensitizing Agents
Figuer Anti-Depressants Figures
Table Key Players of Anti-Depressants
Figuer Ornithine Decarboxylase Inhibitors Figures
Table Key Players of Ornithine Decarboxylase Inhibitors
Figuer Aromatase Inhibitors Figures
Table Key Players of Aromatase Inhibitors
Figuer Diuretics Figures
Table Key Players of Diuretics
Table Global Polycystic Ovary Syndrome Treatment Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Polycystic Ovary Syndrome Treatment Market Share by Application in 2018 & 2025
Figure Hospital Pharmacies Case Studies
Figure Drug Stores Case Studies
Figure Polycystic Ovary Syndrome Treatment Report Years Considered
Figure Global Polycystic Ovary Syndrome Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Polycystic Ovary Syndrome Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Polycystic Ovary Syndrome Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Polycystic Ovary Syndrome Treatment Market Share by Regions 2014-2019
Figure Global Polycystic Ovary Syndrome Treatment Market Share by Regions 2014-2019
Figure Global Polycystic Ovary Syndrome Treatment Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Polycystic Ovary Syndrome Treatment Revenue by by Players (2014-2019) (Million US$)
Table Global Polycystic Ovary Syndrome Treatment Market Share by by Players (2014-2019)
Figure Global Polycystic Ovary Syndrome Treatment Market Share by by Players in 2018
Table Global Polycystic Ovary Syndrome Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Polycystic Ovary Syndrome Treatment Product/Solution/Service
Table Date of Enter into Polycystic Ovary Syndrome Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Polycystic Ovary Syndrome Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Polycystic Ovary Syndrome Treatment Market Size Share by Type (2014-2019)
Figure Global Polycystic Ovary Syndrome Treatment Market Size Market Share by Type (2014-2019)
Table Global Polycystic Ovary Syndrome Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Polycystic Ovary Syndrome Treatment Market Size Share by Application (2014-2019)
Figure Global Polycystic Ovary Syndrome Treatment Market Size Market Share by Application (2014-2019)
Figure Global Polycystic Ovary Syndrome Treatment Revenue Market Share by Application in 2018
Figure North America Polycystic Ovary Syndrome Treatment Market Size 2014-2019 (Million US$)
Table North America Key Players Polycystic Ovary Syndrome Treatment Revenue (2018-2019) (Million US$)
Table North America Key Players Polycystic Ovary Syndrome Treatment Market Share (2018-2019)
Table North America Polycystic Ovary Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table North America Polycystic Ovary Syndrome Treatment Market Share by Type 2014-2019
Table North America Polycystic Ovary Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table North America Polycystic Ovary Syndrome Treatment Market Share by Application 2014-2019
Figure Europe Polycystic Ovary Syndrome Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Polycystic Ovary Syndrome Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Polycystic Ovary Syndrome Treatment Market Share (2018-2019)
Table Europe Polycystic Ovary Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table Europe Polycystic Ovary Syndrome Treatment Market Share by Type 2014-2019
Table Europe Polycystic Ovary Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table Europe Polycystic Ovary Syndrome Treatment Market Share by Application 2014-2019
Figure China Polycystic Ovary Syndrome Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Polycystic Ovary Syndrome Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Polycystic Ovary Syndrome Treatment Market Share (2018-2019)
Table China Polycystic Ovary Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table China Polycystic Ovary Syndrome Treatment Market Share by Type 2014-2019
Table China Polycystic Ovary Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table China Polycystic Ovary Syndrome Treatment Market Share by Application 2014-2019
Figure Japan Polycystic Ovary Syndrome Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Polycystic Ovary Syndrome Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Polycystic Ovary Syndrome Treatment Market Share (2018-2019)
Table Japan Polycystic Ovary Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table Japan Polycystic Ovary Syndrome Treatment Market Share by Type 2014-2019
Table Japan Polycystic Ovary Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table Japan Polycystic Ovary Syndrome Treatment Market Share by Application 2014-2019
Figure Southeast Asia Polycystic Ovary Syndrome Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Polycystic Ovary Syndrome Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Polycystic Ovary Syndrome Treatment Market Share (2018-2019)
Table Southeast Asia Polycystic Ovary Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Polycystic Ovary Syndrome Treatment Market Share by Type 2014-2019
Table Southeast Asia Polycystic Ovary Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Polycystic Ovary Syndrome Treatment Market Share by Application 2014-2019
Figure India Polycystic Ovary Syndrome Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Polycystic Ovary Syndrome Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Polycystic Ovary Syndrome Treatment Market Share (2018-2019)
Table India Polycystic Ovary Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table India Polycystic Ovary Syndrome Treatment Market Share by Type 2014-2019
Table India Polycystic Ovary Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table India Polycystic Ovary Syndrome Treatment Market Share by Application 2014-2019
Figure Central & South America Polycystic Ovary Syndrome Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Polycystic Ovary Syndrome Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Polycystic Ovary Syndrome Treatment Market Share (2018-2019)
Table Central & South America Polycystic Ovary Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table Central & South America Polycystic Ovary Syndrome Treatment Market Share by Type 2014-2019
Table Central & South America Polycystic Ovary Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table Central & South America Polycystic Ovary Syndrome Treatment Market Share by Application 2014-2019
Table Sanofi Company Details
Table Sanofi Revenue in Polycystic Ovary Syndrome Treatment Business 2014-2019 (Million US$)
Figure Sanofi Revenue Growth Rate in Polycystic Ovary Syndrome Treatment Business (2014-2019)
Table Sanofi Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Polycystic Ovary Syndrome Treatment Business 2014-2019 (Million US$)
Figure Novartis AG Revenue Growth Rate in Polycystic Ovary Syndrome Treatment Business (2014-2019)
Table Novartis AG Recent Development
Table Teva Pharmaceutical Industries Limited Company Details
Table Teva Pharmaceutical Industries Limited Revenue in Polycystic Ovary Syndrome Treatment Business 2014-2019 (Million US$)
Figure Teva Pharmaceutical Industries Limited Revenue Growth Rate in Polycystic Ovary Syndrome Treatment Business (2014-2019)
Table Teva Pharmaceutical Industries Limited Recent Development
Table Addex Therapeutics Ltd. Company Details
Table Addex Therapeutics Ltd. Revenue in Polycystic Ovary Syndrome Treatment Business 2014-2019 (Million US$)
Figure Addex Therapeutics Ltd. Revenue Growth Rate in Polycystic Ovary Syndrome Treatment Business (2014-2019)
Table Addex Therapeutics Ltd. Recent Development
Table BIOCAD Company Details
Table BIOCAD Revenue in Polycystic Ovary Syndrome Treatment Business 2014-2019 (Million US$)
Figure BIOCAD Revenue Growth Rate in Polycystic Ovary Syndrome Treatment Business (2014-2019)
Table BIOCAD Recent Development
Table Merck KGaA Company Details
Table Merck KGaA Revenue in Polycystic Ovary Syndrome Treatment Business 2014-2019 (Million US$)
Figure Merck KGaA Revenue Growth Rate in Polycystic Ovary Syndrome Treatment Business (2014-2019)
Table Merck KGaA Recent Development
Table AstraZeneca plc. Company Details
Table AstraZeneca plc. Revenue in Polycystic Ovary Syndrome Treatment Business 2014-2019 (Million US$)
Figure AstraZeneca plc. Revenue Growth Rate in Polycystic Ovary Syndrome Treatment Business (2014-2019)
Table AstraZeneca plc. Recent Development
Table Bristol Myers Squibb Co. Company Details
Table Bristol Myers Squibb Co. Revenue in Polycystic Ovary Syndrome Treatment Business 2014-2019 (Million US$)
Figure Bristol Myers Squibb Co. Revenue Growth Rate in Polycystic Ovary Syndrome Treatment Business (2014-2019)
Table Bristol Myers Squibb Co. Recent Development
Table Ferring Pharmaceuticals, Inc. Company Details
Table Ferring Pharmaceuticals, Inc. Revenue in Polycystic Ovary Syndrome Treatment Business 2014-2019 (Million US$)
Figure Ferring Pharmaceuticals, Inc. Revenue Growth Rate in Polycystic Ovary Syndrome Treatment Business (2014-2019)
Table Ferring Pharmaceuticals, Inc. Recent Development
Table Crinetics Pharmaceuticals, Inc. Company Details
Table Crinetics Pharmaceuticals, Inc. Revenue in Polycystic Ovary Syndrome Treatment Business 2014-2019 (Million US$)
Figure Crinetics Pharmaceuticals, Inc. Revenue Growth Rate in Polycystic Ovary Syndrome Treatment Business (2014-2019)
Table Crinetics Pharmaceuticals, Inc. Recent Development
Table Global Polycystic Ovary Syndrome Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Polycystic Ovary Syndrome Treatment Market Size Share by Regions (2019-2025)
Figure Global Polycystic Ovary Syndrome Treatment Market Size Share by Regions in 2025
Figure North America Polycystic Ovary Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Polycystic Ovary Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Polycystic Ovary Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Polycystic Ovary Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Polycystic Ovary Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Polycystic Ovary Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Polycystic Ovary Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Polycystic Ovary Syndrome Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Polycystic Ovary Syndrome Treatment Market Size by Product (2019-2025)
Figure Global Polycystic Ovary Syndrome Treatment Market Size by Product in 2025
Table Global Polycystic Ovary Syndrome Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Polycystic Ovary Syndrome Treatment Market Size by Application (2019-2025)
Figure Global Polycystic Ovary Syndrome Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

Sanofi、Novartis AG、Teva Pharmaceutical Industries Limited 、Addex Therapeutics Ltd. 、BIOCAD、Merck KGaA、AstraZeneca plc.、Bristol Myers Squibb Co. 、Ferring Pharmaceuticals, Inc.、Crinetics Pharmaceuticals, Inc.

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 多嚢胞性卵巣症候群治療の世界市場：規模・現状・予測(Global Polycystic Ovary Syndrome Treatment Market Size, Status and Forecast 2019-2025)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp